LU Xiao-Xiao, LU Yi, YANG Lin, MA Yang-Yang, WANG Huan-Huan
Department of Neonatology, Children′s Hospital of Fudan University/National Children′s Medical Center/National Health Commission Key Laboratory of Neonatal Diseases, Shanghai 201102, China (Wang H-H, Email: huanhuan_wang@fudan.edu.cn)
Abstract The patient was a male infant, born full-term, admitted to the hospital at 28 days of age due to jaundice for 20 days and abdominal distension for 15 days. The patient developed symptoms of jaundice, hepatosplenomegaly, massive ascites, and progressively worsening liver function leading to liver failure, severe coagulation disorders, and thrombocytopenia one week after birth. Various treatments were administered, including anti-infection therapy, fluid restriction, use of diuretics, use of hepatoprotective and choleretic agents, intermittent paracentesis, blood exchange, and intravenous immunoglobulin, albumin, and plasma transfusions. However, the patient's condition did not improve, and on the 24th day of hospitalization, the family decided to discontinue treatment and provide palliative care. Sequencing of the patient's liver tissue and parental blood samples using whole-exome sequencing did not identify any pathogenic variants that could explain the liver failure. However, postmortem liver tissue pathology suggested congenital hepatic fibrosis (CHF). Given the rarity of CHF causing neonatal liver failure, further studies on the prognosis and pathogenic genes of CHF cases are needed in the future. This article provides a comprehensive description of the differential diagnosis of neonatal liver failure and introduces a multidisciplinary diagnostic and therapeutic approach to neonatal liver failure.
5 Arnon R, Rosenberg HK, Suchy FJ. Caroli Disease, Caroli Syndrome, and Congenital Hepatic Fibrosis[M]//Murray KF, Larson AM. Fibrocystic Diseases of the Liver. Totowa, NJ: Humana Press, 2010: 331-358.
Pan X, Kelly S, Melin-Aldana H, et al. Novel mechanism of fetal hepatocyte injury in congenital alloimmune hepatitis involves the terminal complement cascade[J]. Hepatology, 2010, 51(6): 2061-2068. PMID: 20512994. DOI: 10.1002/hep.23581.
Bersani I, Auriti C, Piersigilli F, et al. Neonatal acute liver failure due to enteroviruses: a 14 years single NICU experience[J]. J Matern Fetal Neonatal Med, 2020, 33(15): 2576-2580. PMID: 30513031. DOI: 10.1080/14767058.2018.1555806.
Zhu B, Du Z, Wang Z, et al. Congenital hepatic fibrosis in children and adults: clinical manifestations, management, and outcome: case series and literature review[J]. Gastroenterol Res Pract, 2020, 21(4): 8284274. PMID: 32382272. PMCID: PMC7191434. DOI: 10.1155/2020/8284274.
Locatelli L, Cadamuro M, Spirlì C, et al. Macrophage recruitment by fibrocystin-defective biliary epithelial cells promotes portal fibrosis in congenital hepatic fibrosis[J]. Hepatology, 2016, 63(3): 965-982. PMID: 26645994. PMCID: PMC4764460. DOI: 10.1002/hep.28382.
[1]
Guideline Development Group of Clinical Practice Guidelines for Meropenem Therapy in Neonatal Sepsis; PekingUniversity Third Hospital; Editorial Department of Chinese Journal of Contemporary Pediatric. Clinical practice guidelines for meropenem therapy in neonatal sepsis (2024)[J]. CJCP, 2024, 26(2): 107-117.
